We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Pascal Juillerat

Pascal Juillerat MD, MSc

Attending Gastroenterologist; Head of IBD Clinical Studies, Clinic for Visceral Surgery and Medicine, Inselspital, Bern University Hospital, Bern, Switzerland

Dr Pascal Juillerat has started his career as a gastroenterologist at Lausanne and Geneva University Hospitals in Switzerland, where he was one of the founders of the Swiss IBD Cohort Study. In 2009, he moved to the United States with a Science National Foundation founding to perform IBD research in epidemiology. He earneda Master’s degree in Epidemiology at the Harvard School of Public Health and enhanced his clinical skills during an Advanced Fellowship in Inflammatory Bowel Disease at the Crohn’s and Colitis Center at the Massachusetts General Hospital in Boston. Since his return to Switzerland in 2011, he works in the academic setting at Bern University Hospital with the ultimate goal to practice both translational and clinical research and clinical activity with the overall management care of Inflammatory Bowel Disease patients.

He is currently the head of the IBD clinical studies and education program at the Inselspital and tightly collaborates with the Laboratory of mucosal immunology of Prof.  Macpherson and Prof. Mckoy at the Bern University Hospital as well as with the Boston University Hospitals (MGH, Brigham and Women’s Hospital).

He has 14 publications as first-author in peer-review journals, and 62 citations in Pubmed.

His h-index is currently 15 (based on Scopus Web of Science citation report Feb. 2015).

Recent Contributions to PracticeUpdate:

  1. Durable Response to Infliximab in Crohn's Disease